69OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach. (25th November 2018) - Tan, D S W; Lassen, U N; Albert, C M; Kummar, S; van Tilburg, C; Dubois, S G; Geoerger, B; Mascarenhas, L; Federman, N; Basu-Mallick, A; Doz, F; Berlin, J D; et al.